These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 121847)

  • 41. Potential application of molecular biology to leprosy research.
    Gillis TP
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):591-2. PubMed ID: 10347585
    [No Abstract]   [Full Text] [Related]  

  • 42. Cell-mediated immunologic status of healthy members of families with a history of leprosy.
    Price MA; Anders EM; Anders RF; Russel DA; Dennis ES
    Int J Lepr Other Mycobact Dis; 1975; 43(4):307-13. PubMed ID: 1241686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy.
    Gelber RH; Li F; Cho SN; Byrd S; Rajagopalan K; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):744-51. PubMed ID: 2681457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum lymphocytotoxic activity in leprosy.
    Rasheed FN; Locniskar M; McCloskey DJ; Hasan RS; Chiang TJ; Rose P; de Soldenhoff R; Festenstein H; McAdam KP
    Clin Exp Immunol; 1989 Jun; 76(3):391-7. PubMed ID: 2752595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunologic aspects of lepromatous leprosy as related to the immunoglobulins of external secretions: salivary immunoglobulins.
    Saha K; Chakraborty AK
    Int J Lepr Other Mycobact Dis; 1977; 45(3):261-5. PubMed ID: 411761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is the stage set for lymphoid tissue replacement in active lepromatous leprosy patients?
    Talwar GP
    Lepr India; 1977 Jan; 49(1):1-5. PubMed ID: 895073
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
    Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LDH isozymes with anomalous bands in semen of leprosy patients.
    Sirmour SK; Verma PK; Singh JN; Okhandiar P
    Indian J Lepr; 1998; 70(4):405-9. PubMed ID: 10189590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular immunity in patients with leprosy. Circulating T lymphocytes and their response to PHA in leprosy.
    Kaklamanis E; Drouga M; Kouzoutzakoglou K; Karalis D; Trichopoulos D
    Int J Lepr Other Mycobact Dis; 1977; 45(3):241-7. PubMed ID: 303622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccine trials against leprosy.
    Gupte MD
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):587-9. PubMed ID: 10347583
    [No Abstract]   [Full Text] [Related]  

  • 51. Delipidified cell components of Mycobacterium leprae and its applications.
    Mahadevan PR; Robinson P; Vermani M; Pardhy A; Joshi S
    Indian J Lepr; 1991; 63(3-4):371-87. PubMed ID: 1804891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.
    Bjune G; Barnetson RS; Ridley DS; Kronvall G
    Clin Exp Immunol; 1976 Jul; 25(1):85-94. PubMed ID: 791549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
    Convit J; Aranzazu N; Pinardi M; Ulrich M
    Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Light and electron microscopic study of peripheral nerve damage in patients with lepromatous leprosy (LL) and borderline lepromatous leprosy (BL).
    Kajihara H; Paturusi IA; Saleh RM; Rasyad C; Ikuta Y
    Hiroshima J Med Sci; 2000 Mar; 49(1):83-92. PubMed ID: 10824461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunologic aspects of leprosy as related to leucocytic isoantibodies and platelet aggregating factors.
    Saha K; Dutta RN; Mittal MM
    Int J Lepr Other Mycobact Dis; 1975; 43(3):239-48. PubMed ID: 1082859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phytohaemagglutinin (PHA)-induced transformation of peripheral blood-lymphocytes in leprosy patients.
    Ghei SK; Sengupta U; Ramu G
    Lepr India; 1980 Apr; 52(2):223-8. PubMed ID: 6969819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Passive transfer of immunity in lepromatous leprosy patients by Lawrence's transfer factor.
    Mittal MM; Saha K; Maheswari HB
    J Indian Med Assoc; 1976 May; 66(9):197-9. PubMed ID: 965758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.